
PEPA, which is short for 4-[2-(Phenylsulphonylamino)ethylthio]-2,6-difluorophenoxyacetamide, is an investigational new medicine being studied for its potential as treatment for neurological and psychological disorders. It is a sulfonylamino compound that is classified as an ampakine based on its mechanism of action. PEPA induces positive improvements to the cognitive processes of the brain by modulating the AMPA […]